biocortex ltd

Live StartupSmall

biocortex ltd Company Information

Share BIOCORTEX LTD

Company Number

13287534

Shareholders

biocortex inc

biocortex inc.

Group Structure

View All

Industry

Research and experimental development on biotechnology

 

Registered Address

167-169 great portland street, london, W1W 5PF

Website

-

biocortex ltd Estimated Valuation

£1.4m

Pomanda estimates the enterprise value of BIOCORTEX LTD at £1.4m based on a Turnover of £1.2m and 1.16x industry multiple (adjusted for size and gross margin).

biocortex ltd Estimated Valuation

£0

Pomanda estimates the enterprise value of BIOCORTEX LTD at £0 based on an EBITDA of £-2m and a 4.63x industry multiple (adjusted for size and gross margin).

biocortex ltd Estimated Valuation

£2.3m

Pomanda estimates the enterprise value of BIOCORTEX LTD at £2.3m based on Net Assets of £1.4m and 1.59x industry multiple (adjusted for liquidity).

Edit your figures and get a professional valuation report.

Biocortex Ltd Overview

Biocortex Ltd is a live company located in london, W1W 5PF with a Companies House number of 13287534. It operates in the research and experimental development on biotechnology sector, SIC Code 72110. Founded in March 2021, it's largest shareholder is biocortex inc with a 60.9% stake. Biocortex Ltd is a startup, small sized company, Pomanda has estimated its turnover at £1.2m with unknown growth in recent years.

View Sample
View Sample
View Sample

Biocortex Ltd Health Check

Pomanda's financial health check has awarded Biocortex Ltd a 3.5 rating. We use a traffic light system to show it exceeds the industry average on 3 measures and has 4 areas for improvement. Company Health Check FAQs

Health Check Image
Health Rating3.5out of 5
positive_score

3 Strong

positive_score

2 Regular

positive_score

4 Weak

size

Size

annual sales of £1.2m, make it smaller than the average company (£3.7m)

£1.2m - Biocortex Ltd

£3.7m - Industry AVG

growth

Growth

There is insufficient data available for this Key Performance Indicator!

- - Biocortex Ltd

- - Industry AVG

production

Production

with a gross margin of 53.7%, this company has a comparable cost of product (53.7%)

53.7% - Biocortex Ltd

53.7% - Industry AVG

profitability

Profitability

an operating margin of -171.4% make it less profitable than the average company (-5.6%)

-171.4% - Biocortex Ltd

-5.6% - Industry AVG

employees

Employees

with 13 employees, this is below the industry average (46)

13 - Biocortex Ltd

46 - Industry AVG

paystructure

Pay Structure

on an average salary of £77.1k, the company has an equivalent pay structure (£77.1k)

£77.1k - Biocortex Ltd

£77.1k - Industry AVG

efficiency

Efficiency

resulting in sales per employee of £92.1k, this is less efficient (£124.5k)

£92.1k - Biocortex Ltd

£124.5k - Industry AVG

debtordays

Debtor Days

There is insufficient data available for this Key Performance Indicator!

- - Biocortex Ltd

- - Industry AVG

creditordays

Creditor Days

its suppliers are paid after 63 days, this is slower than average (51 days)

63 days - Biocortex Ltd

51 days - Industry AVG

stockdays

Stock Days

There is insufficient data available for this Key Performance Indicator!

- - Biocortex Ltd

- - Industry AVG

cashbalance

Cash Balance

has cash to cover current liabilities for 281 weeks, this is more cash available to meet short term requirements (33 weeks)

281 weeks - Biocortex Ltd

33 weeks - Industry AVG

debtlevel

Debt Level

it has a ratio of liabilities to total assets of 7.1%, this is a lower level of debt than the average (51.3%)

7.1% - Biocortex Ltd

51.3% - Industry AVG

BIOCORTEX LTD financials

EXPORTms excel logo

Biocortex Ltd's latest turnover from March 2024 is estimated at £1.2 million and the company has net assets of £1.4 million. According to their latest financial statements, Biocortex Ltd has 13 employees and maintains cash reserves of £582.8 thousand as reported in the balance sheet.

Data source: Companies HousePomanda Estimates

Mar 2024Mar 2023Mar 2022
Turnover1,197,441544,61222,692
Other Income Or Grants
Cost Of Sales554,087253,09311,661
Gross Profit643,354291,52011,030
Admin Expenses2,696,0071,096,53025,613
Operating Profit-2,052,653-805,010-14,583
Interest Payable15,57510,256
Interest Receivable107,38780,8201,107
Pre-Tax Profit-1,945,266-739,765-23,733
Tax
Profit After Tax-1,945,266-739,765-23,733
Dividends Paid
Retained Profit-1,945,266-739,765-23,733
Employee Costs1,002,415359,60272,980
Number Of Employees1351
EBITDA*-2,042,982-802,709-14,537

* Earnings Before Interest, Tax, Depreciation and Amortisation

Mar 2024Mar 2023Mar 2022
Tangible Assets103,37443,7562,314
Intangible Assets24,499608243
Investments & Other
Debtors (Due After 1 year)
Total Fixed Assets127,87344,3642,557
Stock & work in progress
Trade Debtors
Group Debtors714,174
Misc Debtors99,906138,79915,905
Cash582,7893,508,153295,138
misc current assets
total current assets1,396,8693,646,952311,043
total assets1,524,7423,691,316313,600
Bank overdraft303,893
Bank loan
Trade Creditors 96,203123,4116,480
Group/Directors Accounts200,000
other short term finances
hp & lease commitments
other current liabilities11,5855,68524,960
total current liabilities107,788329,096335,333
loans
hp & lease commitments
Accruals and Deferred Income
other liabilities
provisions
total long term liabilities
total liabilities107,788329,096335,333
net assets1,416,9543,362,220-21,733
total shareholders funds1,416,9543,362,220-21,733
Mar 2024Mar 2023Mar 2022
Operating Activities
Operating Profit-2,052,653-805,010-14,583
Depreciation9,5892,24619
Amortisation825527
Tax
Stock
Debtors675,281122,89415,905
Creditors-27,208116,9316,480
Accruals and Deferred Income5,900-19,27524,960
Deferred Taxes & Provisions
Cash flow from operations-2,739,571-827,947998
Investing Activities
capital expenditure-93,180-44,108-2,603
Change in Investments
cash flow from investments-93,180-44,108-2,603
Financing Activities
Bank loans
Group/Directors Accounts-200,000200,000
Other Short Term Loans
Long term loans
Hire Purchase and Lease Commitments
other long term liabilities
share issue4,123,7182,000
interest107,38765,245-9,149
cash flow from financing-92,6134,388,963-7,149
cash and cash equivalents
cash-2,925,3643,213,015295,138
overdraft-303,893303,893
change in cash-2,925,3643,516,908-8,755

biocortex ltd Credit Report and Business Information

Very Low Risk70 - 100
Low Risk50 - 70
Moderate Risk30 - 50
High Risk20 - 30
Very High Risk0 - 20
Get a comprehensive credit check for biocortex ltd. Get real-time insights into biocortex ltd's credit score, group structure and payment trends.

From as little as £6.99

This will not impact your credit rating!

View Credit Report Sample

Biocortex Ltd Competitor Analysis

competitor_analysis_table_img

Perform a competitor analysis for biocortex ltd by selecting its closest rivals, whether from the PROFESSIONAL, SCIENTIFIC AND TECHNICAL ACTIVITIES sector, other small companies, companies in W1W area or any other competitors across 12 key performance metrics.

biocortex ltd Ownership

BIOCORTEX LTD group structure

Biocortex Ltd has no subsidiary companies.

Ultimate parent company

BIOCORTEX INC

#0153741

2 parents

BIOCORTEX LTD

13287534

BIOCORTEX LTD Shareholders

biocortex inc 60.86%
biocortex inc. 39.14%

biocortex ltd directors

Biocortex Ltd currently has 4 directors. The longest serving directors include Muhannad Al-Omari (Mar 2021) and Dr Nikhil Sharma (Mar 2021).

officercountryagestartendrole
Muhannad Al-OmariEngland36 years Mar 2021- Director
Dr Nikhil SharmaEngland51 years Mar 2021- Director
Mr Hussein KanjiUnited Kingdom48 years Oct 2022- Director
Mr Edward KliphuisFrance40 years Oct 2022- Director

P&L

March 2024

turnover

1.2m

+120%

operating profit

-2.1m

0%

gross margin

53.8%

+0.37%

turnover

Turnover, or revenue, is the amount of sales generated by a company within the financial year.

Balance Sheet

March 2024

net assets

1.4m

-0.58%

total assets

1.5m

-0.59%

cash

582.8k

-0.83%

net assets

Total assets minus all liabilities

Similar Companies

Similar companies unavailable for this selection

biocortex ltd company details

company number

13287534

Type

Private limited with Share Capital

industry

72110 - Research and experimental development on biotechnology

incorporation date

March 2021

age

4

incorporated

UK

ultimate parent company

BIOCORTEX INC

accounts

Total Exemption Full

last accounts submitted

March 2024

previous names

N/A

accountant

-

auditor

-

address

167-169 great portland street, london, W1W 5PF

Bank

-

Legal Advisor

-

biocortex ltd Charges & Mortgages

A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.

We did not find charges/mortgages relating to biocortex ltd.

biocortex ltd Capital Raised & Share Issues BETA

When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.

Click to start generating capital raising & share issue transactions for BIOCORTEX LTD. This can take several minutes, an email will notify you when this has completed.

biocortex ltd Companies House Filings - See Documents

datedescriptionview/download